Pharmacytimes: Condition Center: Acid Reflux Acid Reflux en-us Thu, 30 Jul 2015 02:03:27 UTC Thu, 30 Jul 2015 02:03:27 UTC OTC Options for Heartburn: The Role of the Pharmacist More and more proton pump inhibitors (PPIs) are making the jump to OTC status, and this plethora of new options may confuse patients. Mon, 20 Jul 2015 05:42:00 UTC Drugs of Choice for Barrett’s Esophagus Barrett’s esophagus (BE) is a serious gastrointestinal condition in which acid reflux predisposes the esophagus to increased cell proliferation and decreased apoptosis. Thu, 28 May 2015 06:18:00 UTC Helping Heartburn Patients Navigate OTC Options Relief for heartburn and acid reflux is often found in OTC medication aisles. Wed, 13 May 2015 04:26:00 UTC Proton Pump Inhibitors: Potential Changes in Gastric Fluid Researchers have designed many studies to determine whether long-term proton pump inhibitor use causes changes in the body. Tue, 05 May 2015 03:00:00 UTC Acid Reflux Common Among Women Taking Bisphosphonates Gastroprotective agents may be needed in postmenopausal women taking bisphosphonates. Sat, 18 Apr 2015 02:00:00 UTC Opioids Plus Peptic Ulcer Prescriptions: Red Flag at Discharge Pharmacists are positioned to educate and monitor older patients who are discharged on these medications. Fri, 03 Apr 2015 04:00:00 UTC Preventing Progression to Cancer in Barrett’s Esophagus Since patients with Barrett’s esophagus seem to progress to cancerous stages faster than others, health care professionals might perceive that controlling acid reflux would prevent the transition. Thu, 05 Mar 2015 03:00:00 UTC Treating Acid Reflux May Increase Atrial Fibrillation Ablation Success Gastroesophageal reflux disease and atrial fibrillation are 2 of the most significant health concerns in the United States, and researchers suspect a link between them. Wed, 18 Feb 2015 05:00:00 UTC Interdisciplinary Care Eases Pediatric Aerodigestive Disorder Burden Implementing interdisciplinary care reduces anesthetic exposures and related costs for pediatric patients with complex respiratory and gastrointestinal disorders. Tue, 10 Feb 2015 05:00:00 UTC Combining Baclofen with Omeprazole May Further Reduce GERD Symptoms A recent study suggests that co-administering the muscle relaxant, baclofen, with the proton pump inhibitor (PPI), omeprazole, may be more effective than PPI monotherapy in reducing heartburn and regurgitation in patients with gastroesophageal reflux disease (GERD). Wed, 04 Feb 2015 06:36:00 UTC Does Treatment with Antidepressants Benefit Esophageal Disorders? A systematic review recently reported that antidepressants were beneficial for GERD patients – curbing esophageal sensation and reducing functional chest pain. Thu, 29 Jan 2015 03:48:00 UTC Chronic PPI Use Could Lead to Esophageal Adenocarcinoma Barrett’s esophagus (BE) is a condition in which tissue in the esophagus is replaced by tissue similar to that found in the intestinal lining, which predisposes a patient to esophageal adenocarcinoma (EAC). Tue, 27 Jan 2015 11:00:00 UTC FDA Approves First Nexium Generic The FDA today approved Ivax Pharmaceuticals’ esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca’s proton pump inhibitor Nexium, for the treatment of gastroesophageal reflux disease in patients aged >1 year. Mon, 26 Jan 2015 07:33:00 UTC Weight Loss Reduces Gastric Reflux Symptoms After ringing in the New Year, Americans from all walks of life have started dieting. For the 10% to 20% of Americans who experience gastric reflux, such weight loss may be the key to reducing associated symptoms. Thu, 08 Jan 2015 02:00:28 UTC Patient Complexity Creates Barriers to PPI Deprescribing A recent review of inappropriate prescribing among hospitalized older adults revealed that proton pump inhibitors follow only opiates and benzodiazepines as the most frequently misprescribed medications. Sat, 29 Nov 2014 03:02:01 UTC PPIs Increase Risks for Infection, Vitamin Deficiency A new Mayo Clinic study published in Microbiome shows that patients with acid reflux who regularly receive proton pump inhibitors have less diverse gut bacteria, which heightens their risk for bone fractures, vitamin deficiencies, and infections such as Clostridium difficile and pneumonia. Wed, 26 Nov 2014 10:01:01 UTC Down-Titration of PPIs After GERD Symptom Control Patients on 20-mg maintenance doses of esomeprazole reported no more than mild symptom severity. Fri, 07 Nov 2014 04:04:01 UTC Obese Asthmatics Overuse Rescue Medications As a result of confusing sensations of breathlessness with asthma symptoms, overweight and obese children tend to report poorer asthma control and overuse rescue medications. Thu, 23 Oct 2014 06:00:01 UTC Predicting Partial Response to PPI Therapy As nearly one-third of patients with gastroesophageal reflux disease are partial responders to proton pump inhibitors (PPIs), health care professionals could benefit from reliable methods that predict who will respond to PPIs and who will not. Thu, 16 Oct 2014 06:42:01 UTC New Portal Makes Patient-Reported Gastroesophageal Reflux Disease Outcomes Easier to Assess The My GI Health tool tracks symptoms of gastroesophageal reflux disease over time, helping clinicians save time and improve patient care. Sun, 14 Sep 2014 05:37:25 UTC